Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Small Cell Lung Cancer (Squamous or Non Squamous)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03676192
What this trial is testing

To Compare Efficacy and Safety of CT-P16 and European Union-Approved Avastin as First-Line Treatment for Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of Lung
Celltrion 689
Testing effectiveness (Phase 2)Ended earlyNCT05469178
What this trial is testing

A Clinical Study of Bemcentinib With Standard of Care Chemoimmunotherapy in Untreated Advanced/Metastatic Non-small Cell Lung Cancer Patients With a Mutation in the STK11 Gene

Who this might be right for
Carcinoma, Non-Small-Cell Lung
BerGenBio ASA 26
Testing effectiveness (Phase 2)Ended earlyNCT04139317
What this trial is testing

Safety and Efficacy of Capmatinib (INC280) Plus Pembrolizumab vs Pembrolizumab Alone in NSCLC With PD-L1≥ 50%

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Novartis Pharmaceuticals 76
Large-scale testing (Phase 3)WithdrawnNCT06093503
What this trial is testing

Study of Intravenous Telisotuzumab Vedotin in Combination Osimertinib or Standard of Care Chemotherapy to Assess Change in Disease Activity in Adult Participants With Non-Small Cell Lung Cancer That Has a Mutation in the Epidermal Growth Factor Receptor Gene and That Overexpresses the c-Met Protein

Who this might be right for
Non-Small Cell Lung Cancer
AbbVie
Testing effectiveness (Phase 2)Study completedNCT03989115
What this trial is testing

Dose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLC

Who this might be right for
Solid Tumor
Revolution Medicines, Inc. 113
Testing effectiveness (Phase 2)Looking for participantsNCT07034391
What this trial is testing

A Study Evaluating the Efficacy of PD-1 Inhibitor Combined With Denosumab and Chemotherapy in Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Patients With Driver Gene-Negative Status

Who this might be right for
Non-Small Cell Lung Cancer
China Medical University, China 40
Large-scale testing (Phase 3)Study completedNCT02754882
What this trial is testing

A Study Comparing SB8 and Avastin® in Patients With Advanced Non-squamous Non-small Cell Lung Cancer

Who this might be right for
Lung CancerNon-small Cell Lung Cancer
Samsung Bioepis Co., Ltd. 763
Testing effectiveness (Phase 2)Study completedNCT00070486
What this trial is testing

Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 140
Large-scale testing (Phase 3)Looking for participantsNCT07005102
What this trial is testing

Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
AbbVie 854
Early research (Phase 1)Active Not RecruitingNCT06238479
What this trial is testing

LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Solid TumorRecurrent Solid TumorAdvanced Solid Tumor+11 more
Eli Lilly and Company 490
Not applicableStudy completedNCT02285361
What this trial is testing

GIOTRIF rPMS in Korean Patients With NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 1,272
Testing effectiveness (Phase 2)Ended earlyNCT03366766
What this trial is testing

Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung Cancer

Who this might be right for
Non-Squamous Non-Small Cell Lung CarcinomaStage I Non-Small Cell Lung CancerStage IA Non-Small Cell Lung Carcinoma+5 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 14
Post-approval studies (Phase 4)Looking for participantsNCT07405086
What this trial is testing

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

Who this might be right for
Advanced Biliary Tract CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Hepatocellular Carcinoma+18 more
OHSU Knight Cancer Institute 160
Testing effectiveness (Phase 2)Active Not RecruitingNCT06933329
What this trial is testing

Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
BicycleTx Limited 73
Not applicableStudy completedNCT01614002
What this trial is testing

A Non Interventional Study With Doce Onkovis (Docetaxel) Utilized for the Treatment of Cancer

Who this might be right for
Carcinoma
Onkovis GmbH 371
Early research (Phase 1)Study completedNCT02635672
What this trial is testing

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

Who this might be right for
Neoplasms
Vincerx Pharma, Inc. 110
Not applicableUnknownNCT00242983
What this trial is testing

Quality of Life in Patients Who Are Receiving Either Vinorelbine, Gemcitabine, and Docetaxel or Paclitaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
National Hospital Organization Kinki-chuo Chest Medical Center
Testing effectiveness (Phase 2)Looking for participantsNCT07169734
What this trial is testing

Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

Who this might be right for
Cervical Squamous Cell CarcinomaSquamous Non-small-cell Lung CancerColorectal Cancer+2 more
Alentis Therapeutics AG 180
Large-scale testing (Phase 3)Looking for participantsNCT06930794
What this trial is testing

Vebreltinib and Platinum-Containing Double Agents in Subjects With MET-Positive

Who this might be right for
Non-Small Cell Lung Cancer
Beijing Pearl Biotechnology Limited Liability Company 300
Early research (Phase 1)Ended earlyNCT04000529
What this trial is testing

Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies

Who this might be right for
Non-small Cell Lung CarcinomaHead and Neck Squamous Cell CarcinomaEsophageal SCC+2 more
Novartis Pharmaceuticals 122
Next Page